Insulet (PODD) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Insulet (PODD) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -20.77% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.34% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 18.67% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 15.93% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -50.44% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 43.57% |
| 10 | Insulet | 10.27 Bn | 9.74 Bn | 562.60 Mn | 44.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.17% |
| Mar 31, 2026 | 41.26% |
| Dec 31, 2025 | 46.22% |
| Sep 30, 2025 | 188.19% |
| Jun 30, 2025 | 60.13% |
| Mar 31, 2025 | 31.85% |
| Dec 31, 2024 | -7.97% |
| Sep 30, 2024 | 51.21% |
| Jun 30, 2024 | 46.24% |
| Mar 31, 2024 | 64.32% |
| Dec 31, 2023 | 198.40% |
| Sep 30, 2023 | 38.11% |
| Jun 30, 2023 | 11.22% |
| Mar 31, 2023 | 65.80% |
| Dec 31, 2022 | 49.11% |
| Sep 30, 2022 | -44.14% |
| Jun 30, 2022 | -70.69% |
| Mar 31, 2022 | 56.27% |
| Dec 31, 2021 | 99.29% |
| Sep 30, 2021 | 27.02% |